Kicking off #APDSC2024 (Asia Pacific Delivery System Conference 2024), co-hosted by @AustralianCRS, @CRSMalaysia, and the CRS Chinese Taipei local chapters.
Check out more info below!
https://t.co/MelxNYE6ky
Please don't miss the upcoming JCR Best Paper Award Webinar! @KSPST1971
August 30th (Fri). 12:00 UTC, 08:00 ET, 21:00 KTC.
https://t.co/9QzOTuIldV
ID: 821 0368 0115
PW: 817741
History of ChE, BME, Biomaterials, Drug Delivery, Nanotechnology. Bob Langer, Michael Sefton and @NPeppas as ChE grad students in the MIT labs in May 1972
We are delighted and honored to announce that registration for #CRS2024 has SOLD OUT! With 1,650 attendees representing 51 countries, this is sure to be one of our best Annual Meetings yet.
Stay tuned for our upcoming announcement about next year's meeting location. (Hint: 🔔)
The gut microbiota is closely connected to brain barriers.
.@isen_gard & @jfcryan update in @NatRevGastroHep barrier function across the gut–brain axis:
https://t.co/C95KFBRg48
“EPR effect vs. ATR concept” 🎯
Do nanomedicines accumulate in tumors passively or actively?
Is this different in different tumor types, or for soft vs. hard nanoparticles?
How do new targeting mechanisms contribute to clinical impact?
Check out https://t.co/PdkdmsQqKR
Great talks at last night's @KoreaCRS webinar session with Prof. Wooram Park (@SKKU_1398) and Prof. So-Yeon Park (@EwhaWomansUniv). Big thanks to Prof. Hyukjin Lee for moderating the session of the webinar co-hosted by @AustralianCRS and CRSchina.
Understanding the dynamics of the gut #Microbiota over the course of #Cancer treatment regimens and their associated adverse events can help identify microbial features that associate with response to immune checkpoint blockade. https://t.co/8FmKK7YEVy
A nanoparticle delivery paradigm in cancer – the EPR effect - has been challenged, shifting the focus to active delivery mechanisms. In their Review, Warren Chan et al explore passive vs active delivery and the impact on nanoparticle design @TheChanLab
https://t.co/MnhZcUj0z9
Outstanding paper of Prof. Kwangmeyung Kim on chemodrug-loaded nanomedicines for combination cancer immunotherapy published in @KSPST1971. @EwhaWomansUniv
Congrats on the launch of the official Twitter account for the Korean Society of Pharmaceutical Science and Technology and its official journal, the Journal of Pharmaceutical Investigation (https://t.co/3ytRwq3vvg)! @CRSScience
Cancer cell membrane-decorated hybrid liposomes for treating metastatic breast cancer based on enhanced cancer immunotherapy
| Yu Seok Youn, Sungkyunkwan University |
#cellmembrane#hybridliposome#breastcancer#cancerimmunotherapy
https://t.co/tvuDBjPvbe
Delighted to share our group's recent work on a novel anti-fibrosis strategy utilizing hyaluronic acid-bilirubin nanomedicine published in @acsnano (First authored by our group's Ph.D. student @JongyoonShinn). @KoreaCRS@EwhaWomansUniv https://t.co/HS3En6tOFn